4th Munich Point-of-Care Testing Symposium

Point-of-Care Testing at the Interface of Emerging Technologies and New Clinical Applications
11–13 March 2019 | Munich, Germany

4th Munich Point-of-Care Testing Symposium

Point-of-Care Testing at the Interface of Emerging Technologies and New Clinical Applications
11–13 March 2019 | Munich, Germany

Congress Details

Downloads

Online Programme

Print-File

Welcome note

Dear colleagues,

Welcome to the 4th Munich POCT symposium, to be held from 11–13 March 2019. The conference is themed ”Point-of-Care Testing at the Interface of Emerging Technologies and New Clinical Applications“ and organized by the working group POCT of the German Society of Clinical Chemistry and Laboratory Medicine (DGKL), the Heinz-Nixdorf-Chair of Biomedical Electronics and the Institute for Clinical Chemistry and Pathobiochemistry, both Klinikum rechts der Isar of the Technical University of Munich. The venue will be again the campus of the Klinikum rechts der Isar. The congress languages are both German and English.

We expect more than 350–400 attendees for the three-day scientific program. Additionally, there will be an ePoster exposition. Adjacent to the conference, there will also be an industrial expo with more than 30 IVD companies. Please find important information for the symposium and the scientific program under www.poct-symposium.de. To make our conference a success and to ensure the intended thematic scope, we kindly ask you to submit abstracts related to the indicated conference topics.

We cordially invite you to come to Munich. We are sure that the meeting will be interesting and stimulating. You will hopefully return with long lasting impressions of Munich. We are confident you will find the meeting as a memorable and inspiring event that will be both professionally and personally rewarding.

We are looking forward to meeting you in Munich in March 2019!

Peter B. Luppa
Congress President

Oliver Hayden
Director Heinz-Nixdorf-Chair TUM

Jürgen Ruland
Director of the Institute for Clinical Chemistry and Pathobiochemistry TUM